A surge in dealmaking that's helped Chinese biotech and healthcare firms sell their products globally faces several headwinds.
An employee works at Humanwell PuraCap Pharmaceuticals, a major Chinese softgel pharmaceutical manufacturer in Wuhan. Credit: FeatureChina via AP Images
Much as in the world of artificial intelligence, 2025 has begun on a high note for Chinese companies in biotech, with global interest in their work never greater.
An announcement from Keymed Biosciences on a deal made with Timberlyne Therapeutics. Credit: HKEX
But unlike in AI, where U.S. players are feeling the heat and seeking to block Chinese competitors from the market, Chinese biotech companies and their international counterparts have found ways to collaborate so both sides can
Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
A weekly curated reading list on China from Andrew Peaple.
A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our Subscriptions page for details.
A former Google software engineer has been convicted of trade secrets theft and economic espionage in connection with his efforts to launch a start-up in his native China. The Wire China sat in on Ding Linwei’s trial in San Francisco.
The world's biggest battery manufacturer is pushing the limits of battery tech and supplies carmakers around the world — but a path further into the U.S. is far from certain.
Now on podcast platforms everywhere, The Wire China hits the airwaves to take you behind the scenes of the stories we cover each week. We are dedicated to understanding and explaining one of the biggest stories of our time: China’s economic rise and its influence on the world.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy
